Therapeutic immunization with human immunodeficiency virus type 1 (HIV-1) peptide-loaded dendritic cells is safe and induces immunogenicity in HIV-1-infected individuals. [electronic resource]
Producer: 20080311Description: 284-92 p. digitalISSN:- 1556-679X
- Adult
- Aged
- Anti-HIV Agents -- therapeutic use
- Cells, Cultured
- Dendritic Cells -- immunology
- Epitopes -- immunology
- Female
- HIV Infections -- drug therapy
- HIV-1 -- immunology
- Humans
- Immunotherapy -- adverse effects
- Influenza A virus -- immunology
- Injections, Intravenous
- Injections, Subcutaneous
- Interferon-gamma -- biosynthesis
- Leukapheresis
- Leukocytes, Mononuclear -- immunology
- Male
- Middle Aged
- Viral Proteins -- immunology
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.